Company news

hVIVO plc news in 2024

hVIVO plc's news releases, calls and decks from 2024, newest first.

View company

COVID-19 study published in Nature Communications

December 12, 2024

£11.5m RSV contract and notice of trading update

December 10, 2024

Presentation at Jefferies London Healthcare Conf

November 5, 2024

Long Term Incentive Plan/ PDMR Notification

October 11, 2024

Positive results from RSV human challenge trial

October 7, 2024

Launch of full suite of hLAB standalone services

September 30, 2024

Notice of results

August 20, 2024

Euronext cancellation

August 5, 2024

Change of registered address

July 2, 2024

Capital Markets Day & Notice of trading update

July 2, 2024

Influenza 2b field study contract

July 2, 2024

£2.5m contract for Omicron characterisation study

June 3, 2024

Annual Report & Notice of AGM

April 15, 2024

HVIVO achieves record revenue and initiates dividend policy following successful year

April 9, 2024

Long Term Incentive Plan / PDMR Notification

February 15, 2024

Result of Secondary Placing

February 14, 2024

Proposed Secondary Placing of Ordinary Shares

February 14, 2024

Broker change

January 8, 2024

£6.3m HRV contract signed with biotech client

January 2, 2024

Calls in 2024

Decks in 2024